$331.84
Currently 34 wall-street analysts regularly analyze the financials of Alnylam Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 34 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals, Inc. (ALNY) have a share price target of $325.06. This median of share price forecast represents a -2.04% downside from the latest price of $331.84 as on 05.07.25.
As per the chart shown above, analysts believe that the Alnylam Pharmaceuticals, Inc. (ALNY) share price will touch around $325.06 in next 12-months.
Below is a chart showing the percentage difference between Alnylam Pharmaceuticals, Inc.'s share price and its median forecast price. As on 05.07.25, the difference is -0.92%
Based on 34 analysts tracking and researching Alnylam Pharmaceuticals, Inc. (ALNY) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 17 | 16 | 16 |
Outperform | 8 | 8 | 8 |
Hold | 8 | 10 | 10 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |